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Malaria is a serious infectious disease caused by unicellular eukaryotic parasites of the genus 
Plasmodium. Today more than 200 species exist [1], and whole genome sequence data is available 
for around 22 species [2]. At least five different Plasmodium species can infect humans, of which 
Plasmodium falciparum is the major cause of morbidity and mortality worldwide [3]. Other species 
are specific to vertebrates including rodents, birds and lizards. 
 
The parasite moves between vertebrate hosts via the bite of a mosquito, which serves as the 
definitive host and vector. A parasite species is usually restricted in the number of different 
vertebrate host species it is able to infect, as a result of molecular differences, particularly in the 
complex interactions between the erythrocyte host cell and the parasite [4], as well as 
environmental factors [5]. While malaria parasites are vertebrate host specialists, they are vector 
host generalists: human and rodent species can transmit through a variety of Anopheles mosquitoes, 
whereas avian species utilise diverse vector taxa including culicine mosquitoes such as those in the 
genera Aedes and Culex. During their life-cycles in the two hosts, malaria parasites must adapt to a 
variety of environmental changes, for example in temperature, oxygen levels, and nutrient 
accessibility, inhabiting different tissues and cells within the vertebrate host, and being 
predominantly extracellular in the invertebrate host. In these transits the parasite requires different 
sets of proteins to successfully colonize and survive in different host niches. As a result, there are 
major differences in patterns of gene expression at different lifecycle stages [6], and this is achieved 
through a very tight control of the cell cycle and differentiation processes, which are sensitive to 
environmental stimuli. 
 
Malaria parasites share common genomic features such as the division of the nuclear genome into 
14 chromosomes, and the presence of two extra-chromosomal elements, the mitochondrial and 
apicoplast genomes. Extensive genome sequence data exists for >20 Plasmodium species, revealing 
a general similarity in size (18-33 Mb) and gene number (5000-7800) [2]. More closely-related 
Plasmodium species exhibit syntenic blocks of genes, but generally exhibit high divergence in the 
sub-telomeric regions [7, 8]. The biological and genomic similarities between the Plasmodium 
species have been exploited particularly to study host-parasite interactions using non-human 
infecting species, as illustrated in this issue by research on simian malaria species described by 
Galinski [9]. Some simian malaria parasite species are capable of causing zoonotic infections in 
humans, and thus they are important as causative agents of human disease [10]. However, P. 
knowlesi and P. cynomolgi in simian hosts have proven valuable as model organisms for the human 
malaria species P. falciparum and P. vivax, for example in following transcriptomic and proteomic 
changes during longitudinal infections. 
 
Functional genomics studies in Plasmodium have been hampered by the unique characteristics of 
the genomes of malaria parasites compared with those of other eukaryotes. One is the AT-richness 
of the genome that varies between species: P. falciparum has one of the most AT-rich genomes 
known to date (>80% A or T overall) and ~90% (A+T) in non- coding regions. As a result, many 
regions of the parasite genome are highly repetitive [11], which together with a biased codon usage, 
has been suggested to contribute to variation in the kinetics of gene expression across the genome 
[12, 13]. Importantly, Plasmodium species appear to lack the canonical non-homologous end joining 
repair mechanisms [14], and so genome engineering techniques like CRISPR-Cas9 and zinc-finger 
nuclease technologies [15] rely on homologous recombination mechanisms to repair double-strand 
breaks in these organisms. The application of CRISPR/Cas9 in Plasmodium research is described in 
this issue by Lee and colleagues [16]. They describe the many uses of the CRISPR/Cas9 system for 
genome editing, since the first reported use in Plasmodium in 2014, and provide a thorough analysis 
of the factors to be considered in designing a CRISPR/Cas9 experiment. Their review also provides a 
tantalising vision of the future uses of the CRISPR system to alter transcription and to modify the 
epigenetic landscape of the genome. 
 
In Plasmodium, like other eukaryotes, the regulation of gene expression during development occurs 
via a combination of transcriptional mechanisms, the amount of mRNA that is produced from a 
particular gene, and post-transcriptional mechanisms that regulate the translation of mRNA into 
proteins. In addition, translational and post-translational regulation operate at certain points in the 
parasite life-cycle, i.e. transmissible stages, where a delay between transcript and protein levels of 
nearly 30% has been documented [17]. Both chromatin-mediated and epigenetic processes, the 
latter occurring as non-genetic heritable changes in gene expression, play a key role in the dynamics 
of transcriptional regulation during development, and in parasite-host adaptation. The control 
mechanisms have been extensively studied only in Plasmodium falciparum. 
 
Plasmodium genes display a conventional bipartite promoter architecture, with a transcription 
initiation site immediately upstream of the coding sequence that is required for baseline 
transcriptional activity, and a variable number of upstream cis-regulatory sequences that are bound 
by transcription factors (monocistronic model [18]). In Plasmodium there is only one family of 
transcription factors with master roles in the regulation of transcription. The Apicomplexan AP2 
(ApiAP2) family includes 27 members [19, 20], an extremely low number of DNA binding proteins 
compared with the diversity and abundance of transcription factors identified in other eukaryotes. 
These transcription factors are expressed in a highly stage specific manner and bind to the 
promoters of different functional sets of genes that are activated at different times through parasite 
development. Toenhake & Bartfai in this issue [21] review the peculiarities of core promoter 
recognition in the compact and AT-rich Plasmodium genome, and how the transcriptional apparatus 
and other DNA-associated proteins have adapted to these unique genomic characteristics. Their 
review stresses the important role of cis-regulatory sequences and DNA binding proteins involved in 
life cycle progression during blood-stage development. That is, together with ApiAP2 transcription 
factors, chromatin remodelling proteins are also emerging as important regulators of developmental 
progression and the interaction of transcription factors with their cognate sequences. The authors 
also provide an overview of approaches directed towards the characterization of these gene 
regulatory networks in Plasmodium, such as chromatin accessibility profiling, and how these 
advances are being used to add insights into the stage-specific and clone-specific regulatory 
elements involved in transcriptional activation.  
 
In Plasmodium, like in other eukaryotes, the structure and function of chromatin is dynamic and 
contributes chiefly to the regulation of gene expression. Among chromatin-associated processes the 
most studied are histone variants and post-translational modifications (PTMs) of histones. 
Plasmodium genomes encode a canonical form of each core histone, which are common to other 
eukaryotes, plus four histone variants H2A.Z, H2B.Z, H3.3 and a centromere-specific H3 (CenH3) [22]. 
Previous studies have revealed that both histone variant replacement and various histone PTMs are 
dynamically regulated through Plasmodium development and are known to alter chromatin 
structure and affect levels of transcription [23-25]. Most of the Plasmodium genome is in an 
euchromatic active state and is marked with the variant histones H2A.Z and H2B.Z as well as the 
histone modifications H3K4me3, H3K9ac and H4K8ac. Telomeres and sub-telomeric repeats are 
regions of constitutive heterochromatin that are marked with the repressive histone modification 
mark H3K9me3 and enriched in binding of heterochromatin protein 1 (HP1). Between these two are 
regions of bistable chromatin that switch between active (H3K9ac) and silent (H3K9me3/HP1) 
functional states depending on the phase of the cell cycle and in response to environmental 
conditions [26, 27]. 
 
At higher levels of chromatin structure, the position and distribution of nucleosomes and how the 
chromatin fibre is organized and located within the nucleus impose another layer of transcriptional 
control. 
In this issue Abel and Le Roch review the link between “form and function” of the Plasmodium 
genome at various levels: chromatin structure, nucleosome dynamics and 3D genome organization 
[28].The authors describe key similarities and differences at the level of the core promoters, 
including a divergent TFIID complex, histone PTMs and histone variants contributing to chromatin 
structure, and discuss the current debate surrounding nucleosome landscapes in Plasmodium. The 
review also explores chromosome conformation capture (3C)-based methods to study 3D nuclear 
architecture, and how chromatin structure and the nucleus itself are heavily remodelled during the 
asexual, sexual and transmission stages of the life cycle of P. falciparum, with a particular focus on 
virulence genes. 
 
Perhaps the most striking and yet most dangerous attribute of Plasmodium parasites, is their 
adaptive potential. Natural genomic and phenotypic variation exist in the parasites found in disease-
endemic regions. In addition to standing genetic variation, malaria parasites are masters in their 
ability to be plastic. To cope with environmental heterogeneity malaria parasites have evolved 
mechanisms for rapid evolutionary change, including genetic and non-genetic mechanisms. In this 
issue, Cowell and Winzeler describe one of the important consequences of this evolutionary 
plasticity: the evolution of resistance, usually through mutation, to almost all antimalarial drugs that 
have ever been used to treat the disease [29]. 
 
Apart from genetic changes that affect transcript levels, epigenetic variation contributes chiefly to 
phenotypic variation and plasticity in Plasmodium. This plasticity is key for adaptation of malaria 
parasites to changes in their environment. That is, Plasmodium possesses the ability to generate and 
maintain cell-to-cell transcriptional variability for genes that relate to growth, virulence and 
transmission. This ability is fundamental for parasite transmission and survival in heterogenous 
environments. Llorà-Batlle and colleagues review the underlying epigenetic mechanisms that allow 
the parasite to alter its transcriptome and switch between alternative phenotypes [30]. They 
distinguish between transcriptional changes driven by stochastic events, and those that occur in 
response to external cues. Transcriptional variation has been studied mainly in the blood stages of 
the parasite under in vitro conditions, while little is known about gene regulation in vivo and in other 
stages of the parasite. In contrast to the other reviews in this issue, Gómez-Díaz & Ruiz focus on 
transcriptional regulation and plasticity during development and adaptation in the life-cycle of the 
parasite in the mosquito host [31]. The authors describe the transcriptomes and epigenomes of the 
parasite in the mosquito stages, the master regulators involved in mosquito-life cycle transitions, 
and the existing evidence of epigenetic and transcriptional variation. They finally advocate the 
potential of the mosquito to study Plasmodium gene regulation and transcriptional plasticity in vivo. 
 
The seven reviews in this special issue thus set out a comparative and integrative view of state-of-
the art functional genomics in different Plasmodium species. The authors describe how these 
organisms modify their genomes and epigenomes, and regulate gene expression in order to 
generate phenotypic plasticity, which ultimately allows the parasites to adapt to changing 
environments during their two-host lifecycle, and contribute to their virulence and pathogenesis.  
 
This is a fast-moving field, and technological advances will soon allow single-cell transcriptomic and 
epigenomic analyses, and fine-mapping of variation between parasites within individual hosts. In 
addition, we anticipate that many of the current limitations faced by functional genomics studies in 
malaria will be overcome, including the possibility to study the non-culturable human malaria 
species, that contribute to human morbidity and mortality. Understanding the mechanisms malaria 
parasites use to regulate their genomes through the whole parasite life-cycle, how they differ among 
species, how malaria parasites adapt to the heterogeneous environment of their hosts, are some of 
the challenges that the field faces over the coming years. This knowledge will be fundamental for the 
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